BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Oguz EG, Atilgan KG, Cimen SG, Sahin H, Selen T, Ebinc FA, Cimen S, Ayli MD. COVID-19 infection in a kidney transplant recipient—special emphasis on pharmacokinetic interactions: A case report. World J Transplant 2020; 10(11): 365-371 [PMID: 33312897 DOI: 10.5500/wjt.v10.i11.365] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Hsu JY, Mao YC, Liu PY, Lai KL. Pharmacology and Adverse Events of Emergency-Use Authorized Medication in Moderate to Severe COVID-19. Pharmaceuticals (Basel) 2021;14:955. [PMID: 34681179 DOI: 10.3390/ph14100955] [Reference Citation Analysis]
2 Dęborska-Materkowska D, Kamińska D. The Immunology of SARS-CoV-2 Infection and Vaccines in Solid Organ Transplant Recipients. Viruses 2021;13:1879. [PMID: 34578460 DOI: 10.3390/v13091879] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Jasuja S, Sagar G, Bahl A, Verma S. COVID-19 Infection Clinical Profile, Management, Outcome, and Antibody Response in Kidney Transplant Recipients: A Single Centre Experience. Int J Nephrol 2021;2021:3129411. [PMID: 34616572 DOI: 10.1155/2021/3129411] [Reference Citation Analysis]